News
US poll reveals ‘significant’ gaps in women’s knowledge about cervical cancer
Over 70 per cent of women have delayed getting a Pap test, the US medtech company BD has found

New findings indicate a significant gap in women’s knowledge about the primary causes of cervical cancer and the most effective means of prevention.
Despite being one of the few cancers that is almost entirely preventable, according to the American Cancer Society (ACS), 14,000 women in the US are diagnosed with cervical cancer every year and more than 4,000 women die from it.
The online survey of US women between 18 and 64, conducted by The Harris Poll, found that 71 per cent of respondents have delayed getting a Pap test, also known as a smear test.
Detecting cervical cancer early with a Pap smear can give women a greater chance at a cure. The test can also detect changes in a woman’s cervical cells that suggest cancer may develop in the future.
However, if the changes are not detected and treated appropriately, precancerous cells can turn into cervical cancer, experts warn.
Around 15 per cent of American women say their last OB/GYN visit for a routine care or check-up was more than three years ago, with nearly one in 10 saying they have never had a Pap test.
About one in 10 hispanic and black women say they have never had an OB/GYN visit for routine care and similar proportions say they have never had a Pap test.
When asked why they have delayed getting a Pap test, Hispanic women are more likely to report feeling embarrassed, afraid it would hurt or unable to access a OB/GYN.
“Racial and ethnic minorities, rural residents, sexual and gender minorities and those with limited English proficiency often face cultural, economic and geographical factors that preclude them from obtaining critical health screenings, including Pap and HPV tests,” said Brooke Story, worldwide president of Integrated Diagnostic Solutions for BD, the US medtech company that published the findings.
“Being that January is Cervical Cancer Awareness Month, there is no better time to analyse the sentiment women hold around such screenings.
“The survey results underscore that lack of knowledge is one of the biggest barriers to receiving timely screening.
“We need more patient-centered communications to educate everyone, including and especially marginalised and underserved groups, in addition to providing greater access to critical diagnostic tools and services.”
As many as 75 per cent of American women say one of their 2023 resolutions would be to get on track with their annual health screening appointments, like OB/GYN visits.
While 91 per cent say they are knowledgeable about women’s health in general, fewer report being knowledgeable about more specific aspects, such as how often they should get a Pap test or HPV test that looks for the virus responsible for causing cervical cancer.
The study found that 67 per cent of American women were unaware that almost all cervical cancers are caused by HPV.
Overall, 47 per cent of American women say they don’t understand the difference between a Pap test and an HPV test, with Black women (58 per cent) more likely to agree with this than non-Hispanic white women (44 per cent).
Similarly, 66 per cent of did not know that nearly all sexually active men and women get HPV at some point in their lives, while 61 per cent did not know there are different types of HPV strains.
More than 50 per cent of American women mistakenly believe that Pap tests screen for a variety of STDs, while 67 per cent mistakenly believe that women aged 30 to 65 need a Pap test every year.
The American College of Obstetricians and Gynecologists (ACOG) and US Preventive Services Task Force recommend screening begin at 21 years of age, with Pap testing every three years and average-risk individuals aged 30 years and older screen every five years with primary HPV testing or co-testing.
The American Cancer Society recommends screening begin at age 25 with primary HPV screening.
Adolescent health
Newly-launched Female Health Hub will support grassroots football players

A new Female Health Hub launched by the English FA will support women and girls in grassroots football in England with trusted advice on health issues affecting play.
The hub brings together expert-backed guidance, practical tools and player insights in one place, giving women and girls practical advice and reassurance on female health in football.
It has four core aims: to help women and girls better understand their bodies and how female health affects performance and participation, to educate players on key health topics and when to seek further advice or support, to provide practical strategies to help navigate common female health challenges, and to help break down taboos and normalise conversations around female health in football.
Users of the hub will also be able to hear directly from members of the England women’s national team, who share their own experiences of navigating female health matters while playing at the highest level of the game.
“Our ambition is to create a game where women and girls can thrive,” said Sue Day, the FA’s director of women’s football.
“To achieve that, it’s essential that players feel supported in environments that understand and respond to their female health needs.
“We’ve heard directly from grassroots players that they want better information and support around female health, but that they often don’t know where to find it.
“The launch of the Female Health Hub marks an important step in changing the landscape.
“We want every player to feel confident in her own skin and supported without judgment, so she can feel empowered by her body, rather than held back by it.”
The platform was launched following research conducted by the FA that highlighted the need for better education and support around female health in football.
According to the FA, 88 per cent of adult players surveyed said their menstrual cycle has an impact on their ability to train or play, but 86 per cent reported they had never received education about the menstrual cycle in relation to football performance and training.
The research also found 64 per cent of women experience issues related to sports bras or breast health while playing football, despite sports bras being considered one of the most important pieces of playing kit.
Players also expressed strong interest in learning more about injury prevention, at 87 per cent, nutrition, at 84 per cent, and mental health, at 77 per cent, in relation to female health.
The first phase of the Female Health Hub focuses on three of the most requested topics: menstrual health, breast health and injury resilience, with further content to follow, including nutrition and pelvic health guidance.
Pregnancy
Women’s health strategy a ‘missed opportunity,’ RCM says
Fertility
Genetic carrier screening before pregnancy: What to know

Article produced in association with London Pregnancy Clinic and Jeen Health
For the majority of couples planning a pregnancy, genetic testing is not something they think about until a problem arises.
Pre-conception genetic carrier screening challenges this approach by identifying risk before pregnancy begins.
As panel sizes have grown and at-home testing options have become widely available, carrier screening is transitioning from a niche clinical referral into a mainstream component of reproductive planning.
What Carrier Screening Tests For
Being a carrier of a genetic condition means carrying one copy of a variant in a gene associated with that condition, without being affected by it.
In most cases, carriers are entirely unaware of their status.
The clinical significance of carrier status emerges when both members of a couple carry a variant in the same gene: in this scenario, each pregnancy carries a one in four chance of resulting in a child who inherits two copies of the variant and is affected by the condition.
The conditions most frequently included in expanded carrier screening panels include cystic fibrosis, spinal muscular atrophy (SMA), fragile X syndrome, sickle cell disease, and a range of metabolic and enzyme deficiency disorders.
The Beacon 787 carrier test, offered by Jeen Health, screens for 787 conditions from a single sample, making it one of the most comprehensive panels currently available to UK families.
Who Is Most Likely to Benefit
Any couple planning a pregnancy can consider carrier screening. It is particularly relevant for:
- Couples with a family history of a known inherited condition
- Those from populations with higher carrier frequencies for specific conditions, including Ashkenazi Jewish, South Asian and African communities
- Couples pursuing fertility treatment, where genetic information informs treatment planning
- Those who wish to have the most complete picture of their reproductive health before conception
Importantly, being a carrier of a condition does not mean a child will be affected. It means there is a defined statistical risk that can be quantified, discussed and planned for with appropriate clinical support.
How the Test Is Performed
Carrier screening is typically carried out on a blood or saliva sample.
For at-home options such as the testing offered by Jeen Health, a cheek swab collection kit is dispatched to the patient, the sample is returned by post, and results are delivered digitally within a defined turnaround period.
In-clinic carrier testing may use a blood draw and provides the advantage of immediate access to a clinical consultation at the point of result delivery.
London Pregnancy Clinic offers genetics counselling through its partnership with Jeen Health, allowing couples to receive and contextualise carrier test results with expert support.
Genetic counselling before and after testing is recommended by Genomics England as a standard component of any genomic testing pathway.
What Happens If Both Partners Are Carriers
If both partners are identified as carriers for the same autosomal recessive condition, they are typically offered further counselling to discuss their options.
These may include proceeding naturally with an awareness of the risk, using prenatal diagnosis (CVS or amniocentesis) during pregnancy to test the fetus, or pursuing preimplantation genetic testing (PGT) in the context of IVF, which allows unaffected embryos to be selected before transfer.
The purpose of identifying carrier status before pregnancy is to give couples time to consider these options without the added pressure of an ongoing pregnancy.
Knowledge of carrier status does not remove reproductive choices; it expands the information available when making them.
The Role of Pre-Conception Services
Carrier screening sits within a broader category of pre-conception care that includes fertility assessments, general health optimisation and, where relevant, management of existing conditions before pregnancy begins.
London Pregnancy Clinic offers pre-conception services encompassing fertility investigations, genetics counselling and carrier testing as part of an integrated 0th trimester approach, allowing couples to address genetic and clinical risk factors before their pregnancy starts rather than after.
Disclaimer: This article is produced for informational purposes only and does not constitute medical advice, diagnosis or treatment.
Clinical guidance referenced reflects published NHS, NICE and RCOG standards as at March 2026. Individual circumstances vary; readers are advised to consult a qualified healthcare professional before acting on any information in this article.
This piece was produced in association with London Pregnancy Clinic and Jeen Health, which provided background clinical information for editorial purposes.
Hyperlinks to external sources are included for reference only and do not represent an endorsement of any product, service or organisation.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Menopause4 weeks agoCalifornia plans US$3.4m menopause care overhaul
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause3 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News2 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Entrepreneur3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up














2 Comments